Sofinnova Investments, Inc. Q3 2024 Filing
Filed November 13, 2024
Portfolio Value
$1.3B
Holdings
58
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (58 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NTRANatera Inc | 1,550,280 | $196.8T | 15619872.14% | |
| 2 | VERAVera Therapeutics Inc | 2,793,987 | $123.5T | 9801245.65% | |
| 3 | NVONovo-Nordisk A S | 726,329 | $86.5T | 6863890.76% | |
| 4 | AZNAstraZeneca PLC | 809,406 | $63.1T | 5004886.65% | |
| 5 | IDYAIDEAYA Biosciences Inc | 1,749,455 | $55.4T | 4398682.05% | |
| 6 | ELANElanco Animal Health Inc | 3,518,684 | $51.7T | 4102387.57% | |
| 7 | BIOABioAge Labs Inc | 2,304,901 | $47.9T | 3804961.25% | |
| 8 | AXSMAxsome Therapeutics Inc | 529,527 | $47.6T | 3776917.26% | Put |
| 9 | INCYIncyte Corp | 714,176 | $47.2T | 3746634.60% | |
| 10 | SLNOSoleno Therapeutics Inc | 886,344 | $44.8T | 3551749.35% | Put |
| 11 | RAPPRapport Therapeutics Inc | 1,995,594 | $40.9T | 3243670.76% | |
| 12 | AVBPArrivent BioPharma Inc | 1,696,752 | $39.9T | 3164614.82% | |
| 13 | YMABUSDY-mAbs Therapeutics Inc | 2,194,278 | $28.9T | 2290087.26% | |
| 14 | DYNDyne Therapeutics Inc | 772,070 | $27.7T | 2201038.43% | |
| 15 | COGTCogent Biosciences Inc | 2,265,230 | $24.5T | 1941648.83% | |
| 16 | YB4PSavara Inc | 5,662,550 | $24.0T | 1905515.70% | |
| 17 | NVSNNovartis AG | 200,000 | $23.0T | 1825736.02% | Put |
| 18 | INZYInozyme Pharma Inc | 4,280,308 | $22.4T | 1776688.69% | |
| 19 | JAZZJazz Pharmaceuticals PLC | 188,562 | $21.0T | 1667296.99% | |
| 20 | IM8NInsmed Inc | 286,307 | $20.9T | 1658782.53% | |
| 21 | SNDXSyndax Pharmaceuticals Inc | 786,999 | $15.1T | 1202373.92% | |
| 22 | RYTMRhythm Pharmaceuticals | 276,678 | $14.5T | 1150423.22% | |
| 23 | EWEdwards Lifesciences Corp | 202,898 | $13.4T | 1062650.67% | |
| 24 | BSXBoston Scientific Corp | 135,819 | $11.4T | 903314.88% | |
| 25 | PHVSPharvaris N V | 600,302 | $11.1T | 882359.16% | |
| 26 | EWTXEdgewise Therapeutics Inc | 384,767 | $10.3T | 815043.91% | |
| 27 | IMNMImmunome Inc | 676,766 | $9.9T | 785272.76% | |
| 28 | GHGuardant Health Inc | 406,645 | $9.3T | 740360.88% | |
| 29 | RVMDRevolution Medicines Inc | 203,271 | $9.2T | 731623.00% | |
| 30 | INBXInhibrx Biosciences Inc | 536,068 | $8.4T | 666263.88% | |
| 31 | TGTXTG Therapeutics Inc | 358,644 | $8.4T | 665776.42% | |
| 32 | AVTEAerovate Therapeutics Inc | 3,758,686 | $7.9T | 623472.03% | |
| 33 | ESTAEstablishment Labs Hldgs Inc | 181,476 | $7.9T | 623219.09% | |
| 34 | MRNS*Marinus Pharmaceuticals Inc | 4,386,177 | $7.7T | 612679.67% | |
| 35 | JANXJanux Therapeutics Inc | 164,770 | $7.5T | 594094.45% | |
| 36 | CABACabaletta Bio Inc | 1,533,883 | $7.2T | 574604.30% | |
| 37 | SP4PAchieve Life Sciences Inc | 1,514,032 | $7.2T | 569571.23% | |
| 38 | KURAKura Oncology Inc | 296,884 | $5.8T | 460411.27% | |
| 39 | PAHCPhibro Animal Health Corp | 238,184 | $5.4T | 425711.73% | |
| 40 | ILMNIllumina Inc | 40,611 | $5.3T | 420328.89% | |
| 41 | ERASErasca Inc | 1,842,668 | $5.0T | 399249.51% | |
| 42 | IMTXImmatics N.V | 386,100 | $4.4T | 349639.16% | |
| 43 | NARIUSDInari Med Inc | 90,327 | $3.7T | 295645.19% | |
| 44 | BDXBecton Dickinson & Co | 15,191 | $3.7T | 290682.03% | |
| 45 | NXTCNextcure Inc | 2,671,856 | $3.7T | 290514.81% | |
| 46 | TMOThermo Fisher Scientific Inc | 5,770 | $3.6T | 283269.17% | |
| 47 | EXASExact Sciences Corp | 37,637 | $2.6T | 203481.15% | |
| 48 | IRONDisc Medicine Inc | 41,352 | $2.0T | 161274.70% | |
| 49 | BOLT1EURBolt Biotherapeutics Inc | 2,754,437 | $1.8T | 141658.43% | |
| 50 | GPCRStructure Therapeutics Inc | 38,792 | $1.7T | 135127.08% | |
| 51 | CATXPerspective Therapeutics Inc | 120,632 | $1.6T | 127813.98% | |
| 52 | RNAAvidity Biosciences Inc | 30,472 | $1.4T | 111079.02% | |
| 53 | VIRVir Biotechnology Inc | 129,246 | $968.1B | 76830.52% | |
| 54 | CATBUSDAstria Therapeutics Inc | 85,640 | $942.9B | 74833.91% | |
| 55 | IMTXImmatics N.V | 366,568 | $852.3B | 67641.36% | |
| 56 | —Ikena Oncology Inc | 382,616 | $661.9B | 52534.43% | |
| 57 | REPLReplimune Group Inc | 48,138 | $527.6B | 41872.88% | |
| 58 | LUNGPulmonx Corp | 62,313 | $516.6B | 40998.50% |